Panellists To CBD: Funds Needed To Save Biodiversity, Genetic Resources Not In Nagoya Protocol Should Be Included 27/11/2018 by Catherine Saez, Intellectual Property Watch 1 Comment SHARM-EL-SHEIKH, Egypt – The access and benefit sharing protocol of the UN Convention on Biological Diversity is based on bilateral agreements between providers and users of genetic resources. There are, however, many cases where genetic resources are dispersed, and difficult to attribute to only one location. The issue is being discussed at the biennial meeting of the CBD member states, in particular the possibility of a global multilateral benefit-sharing mechanism to address those genetic resources not yet covered by the protocol. A side event yesterday explored the possible conditions and needs for establishing such a mechanism, and called for urgent action.
WIPO General Assemblies 2018: External Offices, Treaties, New African Collaborations 21/09/2018 by Catherine Saez, Intellectual Property Watch 1 Comment World Intellectual Property Organization members gather next week for their annual General Assemblies. Among the topics to be discussed is which countries will host new WIPO external offices in 2018-2019. Also on the agenda are the reports from various WIPO committees, with some raising the prospect of convening high-level final negotiations on international treaties next year. A number of side events and exhibitions are also scheduled, focusing on issues like health, women, and innovation.
MPP Board Gives Green Light To Expansion, Now Has To Identify Candidates 28/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The Medicines Patent Pool announced this week that its Board agreed on the extension of the MPP mandate to patented medicines on the World Health Organization Essential Medicines List. The decision follows an extensive feasibility study. During a side event held on the margins of the annual World Health Assembly, Patent Pool officials explained the findings of the study, while in the audience, a representative of the pharmaceutical industry suggested a cautious approach.
Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices 24/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment During a side event held alongside this week’s World Health Assembly, public health advocates proposed that Switzerland use compulsory licensing as a way to decrease what they said are exorbitant drug prices.
KEI Recommends WIPO Study On Running Royalties As Limitation On Remedies 06/07/2017 by Elise De Geyter for Intellectual Property Watch 1 Comment Nonprofit group Knowledge Ecology International (KEI) has requested a study by the World Intellectual Property Organization on the case law of the non-voluntary use of patents as a limitation on remedies, Andrew Goldman, counsel for policy and legal affairs at KEI, said at a side event to a WIPO meeting this week.
Indigenous People Ask For More Involvement in Decision Making At WIPO 15/06/2017 by Elise De Geyter for Intellectual Property Watch 1 Comment Different representatives of indigenous people shared their views and concerns on the protection of the rights of indigenous people and local communities during a side event at the World Intellectual Property Organization this week. Speakers underlined the need of consultation of indigenous people during negotiations about their rights.
Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue.
Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 by Catherine Saez, Intellectual Property Watch 1 Comment A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control.
World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 by Mara Pillinger for Intellectual Property Watch Leave a Comment The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out.
Strong Application Of GIs May Be Detrimental To Generic Products, Speakers Say 14/04/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The protection of geographical indications could impede the ability of long-term producers to continue using what they consider as being generic names, according to several speakers at an event last month at the World Intellectual Property Organization. The discussion is also ongoing at the World Trade Organization in the context of barriers to trade. The side event focused on the case of danbo cheese, a Danish cheese manufactured in several countries, particularly in Uruguay.